Express Scripts 起诉 FTC 2024 年关于 PBM 增加药物成本的诽谤性报告。 Express Scripts sues FTC over defamatory 2024 report on PBMs increasing drug costs.
由Cigna公司拥有的药房福利管理公司Express Scripts,因其2024年7月的报告称PBM增加药物成本而起诉联邦贸易委员会 (FTC). Express Scripts, a pharmacy benefit manager owned by Cigna Corp., has sued the Federal Trade Commission (FTC) over its July 2024 report that claims PBMs increase drug costs. 在密苏里提起的诉讼声称,该报告是诽谤性的,忽视了个人资料机制提供的好处。 The lawsuit, filed in Missouri, alleges the report is defamatory and overlooks the benefits PBMs provide. Express Scripts 认为，药品价格是由制造商而不是 PBM 设定的，并寻求撤回该报告，并警告说它可能损害医疗保健系统并提高消费者的价格。 Express Scripts argues that drug prices are set by manufacturers, not PBMs, and seeks to have the report retracted, warning it could harm the healthcare system and raise prices for consumers.